154 related articles for article (PubMed ID: 15493297)
21. Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus.
Fiorino F; Ciano A; Magli E; Severino B; Corvino A; Perissutti E; Frecentese F; Di Vaio P; Izzo AA; Capasso R; Massarelli P; Nencini C; Rossi I; Kędzierska E; Orzelska-Gòrka J; Bielenica A; Santagada V; Caliendo G
Eur J Med Chem; 2016 Mar; 110():133-50. PubMed ID: 26820556
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of 1,4-disubstituted 2-methylpiperazine derivatives, new 5-HT(1A) receptor ligands.
Cybulski M; Dankiewicz W; Chilmończyk Z
Acta Pol Pharm; 2001; 58(5):357-65. PubMed ID: 11876443
[TBL] [Abstract][Full Text] [Related]
23. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of environment-sensitive fluorescent ligands for human 5-HT1A receptors with 1-arylpiperazine structure.
Lacivita E; Leopoldo M; Masotti AC; Inglese C; Berardi F; Perrone R; Ganguly S; Jafurulla M; Chattopadhyay A
J Med Chem; 2009 Dec; 52(23):7892-6. PubMed ID: 19705871
[TBL] [Abstract][Full Text] [Related]
25. New 5-HT
Fiorino F; Magli E; Kędzierska E; Ciano A; Corvino A; Severino B; Perissutti E; Frecentese F; Di Vaio P; Saccone I; Izzo AA; Capasso R; Massarelli P; Rossi I; Orzelska-Gòrka J; Kotlińska JH; Santagada V; Caliendo G
Bioorg Med Chem; 2017 Oct; 25(20):5820-5837. PubMed ID: 28943244
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands.
Patanè E; Pittalà V; Guerrera F; Salerno L; Romeo G; Siracusa MA; Russo F; Manetti F; Botta M; Mereghetti I; Cagnotto A; Mennini T
J Med Chem; 2005 Apr; 48(7):2420-31. PubMed ID: 15801833
[TBL] [Abstract][Full Text] [Related]
27. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
[TBL] [Abstract][Full Text] [Related]
28. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationship studies of CNS agents. Part 14: Structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives.
Mokrosz JL; Strekowski L; Duszyńska B; Harden DB; Mokrosz MJ; Bojarski AJ
Pharmazie; 1994 Nov; 49(11):801-6. PubMed ID: 7838864
[TBL] [Abstract][Full Text] [Related]
30. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and preliminary evaluation of aminoalkanol derivatives of selected azatricycloundecane system for binding with beta-adrenergic and 5HT1A and 5HT2A receptors.
Kossakowski J; Kuran B
Acta Pol Pharm; 2007; 64(6):527-33. PubMed ID: 18323247
[TBL] [Abstract][Full Text] [Related]
33. Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT1A, 5-HT2A, and D2 receptor activity.
Paluchowska MH; Bugno R; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Feb; 13(4):1195-200. PubMed ID: 15670928
[TBL] [Abstract][Full Text] [Related]
34. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
[TBL] [Abstract][Full Text] [Related]
35. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
Paluchowska MH; Bugno R; Charakchieva-Minol S; Bojarski AJ; Wesołowska A
Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083
[TBL] [Abstract][Full Text] [Related]
36. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands.
Bojarski AJ; Duszyńska B; Kołaczkowski M; Kowalski P; Kowalska T
Bioorg Med Chem Lett; 2004 Dec; 14(23):5863-6. PubMed ID: 15501057
[TBL] [Abstract][Full Text] [Related]
37. Interaction of arylpiperazine ligands with the hydrophobic part of the 5-HT1A receptor binding site.
Zlatović MV; Sukalović VV; Schneider C; Roglić GM
Bioorg Med Chem; 2006 May; 14(9):2994-3001. PubMed ID: 16403641
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands.
Fiorino F; Magli E; Severino B; Corvino A; Ciano A; Perissutti E; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
Arch Pharm (Weinheim); 2014 Oct; 347(10):698-706. PubMed ID: 25113046
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione.
Obniska J; Tatarczyńska E; Nikiforuk A; Charakchieva-Minol S; Duszyńska B
Pharmacol Rep; 2006; 58(1):107-14. PubMed ID: 16531637
[TBL] [Abstract][Full Text] [Related]
40. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2004; 56(6):743-54. PubMed ID: 15662087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
